Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen

Molecular portraits of human breast tumours

Perou, C., Sørlie, T., Eisen, M., van de Rijn, M., Jeffrey, S., Rees, C. A., Pollack, J., Ross, D., Johnsen, H., Akslen, L., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,551 · see citing works

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Sørlie, T., Perou, C., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M., van de Rijn, M., Jeffrey, S., et al. (2001) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.191367098 · Cited by 11,695 · see citing works

pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up

Elston, C. W., & Ellis, I. O. (1991) · Histopathology · doi:10.1111/j.1365-2559.1991.tb00229.x · Cited by 6,181 · see citing works

Repeated observation of breast tumor subtypes in independent gene expression data sets

Sørlie, T., Tibshirani, R. J., Parker, J. S., Hastie, T. J., Marron, J. S., Nobel, A. B., Deng, S., Johnsen, H., Pesich, R., Geisler, S. B., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,428 · see citing works

Tissue microarrays for high-throughput molecular profiling of tumor specimens

Kononen, J., Bubendorf, L., Kallionimeni, A., Barlund, M. T., Schraml, P., Leighton, S. B., Torhorst, J. K. H., Mihatsch, M. J., Sauter, G., & Kallionimeni, O.-P. (1998) · Nature Medicine · doi:10.1038/nm0798-844 · Cited by 4,101 · see citing works

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

Sotiriou, C. P., Neo, S.-Y., McShane, L. M., Korn, E. L., Long, P. M., Jazaeri, A. A., Martiat, P., Fox, S. B., Harris, A. L., & Liu, E. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1732912100 · Cited by 1,993 · see citing works

Pathological prognostic factors in breast cancer

Elston, C. W. (1999) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(99)00034-7 · Cited by 1,741 · see citing works

Predicting the clinical status of human breast cancer by using gene expression profiles

West, M., Blanchette, C., Dressman, H. K., Huang, E. S., Ishida, S., Spang, R., Zuzan, H., Olson, J. A., Marks, J. R., & Nevins, J. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201162998 · Cited by 1,318 · see citing works

The Nottingham prognostic index in primary breast cancer

Galea, M. H., Blamey, R. W., Elston, C. W., & Ellis, I. O. (1992) · Breast Cancer Research and Treatment · doi:10.1007/bf01840834 · Cited by 1,071 · see citing works

Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies.

McCarty, K. S., MILLER, L. S., Cox, E. B., Konrath, J. G., & McCarty, K. S. (1985) · PubMed · Cited by 1,027 · see citing works

The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells

Richardson, D. R., & Ponka, P. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/s0304-4157(96)00014-7 · Cited by 706 · see citing works

Ubiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferrin.

Sutherland, R., Delia, D., Schneider, C., Newman, R., Kemshead, J., & Greaves, M. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.7.4515 · Cited by 685 · see citing works

The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer

Daniels‐Wells, T. R., Delgado, T., Rodríguez, J. A., Helguera, G. F., & Penichet, M. L. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.06.010 · Cited by 630 · see citing works

High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses

El‐Rehim, D. M. A., Ball, G., Pinder, S. E., Rakha, E. A., Paish, C. E., Robertson, J. F. R., Macmillan, D. R., Blamey, R. W., & Ellis, I. O. (2005) · International Journal of Cancer · doi:10.1002/ijc.21004 · Cited by 606 · see citing works

The transferrin receptor: role in health and disease

Ponka, P., & Lok, C. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00070-9 · Cited by 598 · see citing works

Expression of Cytokeratins 17 and 5 Identifies a Group of Breast Carcinomas with Poor Clinical Outcome

van de Rijn, M., Perou, C. M., Tibshirani, R. J., Haas, P., Kallioniemi, O., Kononen, J., Torhorst, J. K. H., Sauter, G., Zuber, M., Köchli, O. R., et al. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64476-8 · Cited by 560 · see citing works

Elevated Levels of Epidermal Growth Factor Receptor/c-erbB2 Heterodimers Mediate an Autocrine Growth Regulatory Pathway in Tamoxifen-Resistant MCF-7 Cells

Knowlden, J. M., Hutcheson, I. R., Jones, H. E., Madden, T., Gee, J. M. W., Harper, M. E., Barrow, D., Wakeling, A. E., & Nicholson, R. I. (2003) · Endocrinology · doi:10.1210/en.2002-220620 · Cited by 521 · see citing works

A gene-expression signature to predict survival in breast cancer across independent data sets

Naderi, A., Teschendorff, A. E., Barbosa‐Morais, N. L., Pinder, S. E., Green, A. R., Powe, D. G., Robertson, J. F. R., Aparicio, S. A. J. R., Ellis, I. O., Brenton, J. D., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209920 · Cited by 257 · see citing works

Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma

El‐Rehim, D. M. A., Pinder, S. E., Paish, C. E., Bell, J. A., Rampaul, R. S., Blamey, R. W., Robertson, J. F. R., Nicholson, R. I., & Ellis, I. O. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602184 · Cited by 256 · see citing works

Invasive lobular carcinoma of the breast: Response to hormonal therapy and outcomes

Rakha, E. A., El‐Sayed, M. E., Powe, D. G., Green, A. R., Habashy, H. O., Grainge, M. J., Robertson, J. F. R., Blamey, R. W., Gee, J. M. W., Nicholson, R. I., et al. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.10.009 · Cited by 253 · see citing works

Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas

Ryschich, E., Huszty, G., Knaebel, H. P., Härtel, M., Büchler, M. W., & Schmidt, J. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.01.036 · Cited by 199 · see citing works

Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance

Rakha, E. A., El‐Rehim, D. M. A., Paish, C. E., Green, A. R., Lee, A. H. S., Robertson, J. F. R., Blamey, R. W., Macmillan, D. R., & Ellis, I. O. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.08.015 · Cited by 193 · see citing works

E‐cadherin expression in invasive non‐lobular carcinoma of the breast and its prognostic significance

Rakha, E. A., Rehim, D. A., Pinder, S. E., Lewis, S. A., & Ellis, I. O. (2005) · Histopathology · doi:10.1111/j.1365-2559.2005.02156.x · Cited by 171 · see citing works

Breast carcinoma with basal differentiation: a proposal for pathology definition based on basal cytokeratin expression

Rakha, E. A., El‐Sayed, M. E., Green, A. R., Paish, E. C., Lee, A. H. S., & Ellis, I. O. (2007) · Histopathology · doi:10.1111/j.1365-2559.2007.02638.x · Cited by 169 · see citing works

Differences in transferrin response and numbers of transferrin receptors in rat and human mammary carcinoma lines of different metastatic potentials

Inoue, T., Cavanaugh, P. G., Steck, P. A., Brünner, N., & Nicolson, G. L. (1993) · Journal of Cellular Physiology · doi:10.1002/jcp.1041560128 · Cited by 115 · see citing works

Prognostic Relevance of Basal Cytokeratin Expression in Operable Breast Cancer

Potemski, P., Kusińska, R., Watała, C. W., Płuciennik, E., Bednarek, A. K., & Kordek, R. (2005) · Oncology · doi:10.1159/000090986 · Cited by 102 · see citing works

Forkhead-box A1 (FOXA1) expression in breast cancer and its prognostic significance

Habashy, H. O., Powe, D. G., Rakha, E. A., Ball, G., Paish, C. E., Gee, J. M. W., Nicholson, R. I., & Ellis, I. O. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.04.020 · Cited by 97 · see citing works

Effects of Transferrin Receptor Blockade on Cancer Cell Proliferation and Hypoxia-Inducible Factor Function and Their Differential Regulation by Ascorbate

Jones, D. T., Trowbridge, I. S., & Harris, A. L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3857 · Cited by 75 · see citing works

p53, Rb, and cyclin D1 expression in human oral verrucous carcinomas

Gimenez-Conti, I. B., Collet, A., Lanfranchi, H. E., Itoiz, M. E., Luna, M. A., Xu, H., Hu, S.-X., Benedict, W. F., & Conti, C. J. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960701)78:1 · Cited by 69 · see citing works

Growth factor signalling and resistance to selective oestrogen receptor modulators and pure anti-oestrogens: the use of anti-growth factor therapies to treat or delay endocrine resistance in breast cancer

Nicholson, R. I., Hutcheson, I. R., Hiscox, S., Knowlden, J. M., Giles, M., Barrow, D., & Gee, J. M. W. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.00991 · Cited by 63 · see citing works

Chronic exposure to fulvestrant promotes overexpression of the c-Met receptor in breast cancer cells: implications for tumour–stroma interactions

Hiscox, S., Jordan, N., Jiang, W. G., Harper, M. E., McClelland, R. A., Smith, C. R., & Nicholson, R. I. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01270 · Cited by 59 · see citing works

Differential transferrin receptor density in human colorectal cancer: A potential probe for diagnosis and therapy.

Prost, A., Ménégaux, F., Langlois, P., Vidal, J. M., Koulibaly, M., Jost, J. L., Duron, J. J., Jp, C., Vayre, P., Aurengo, A., et al. (1998) · International Journal of Oncology · doi:10.3892/ijo.13.4.871 · Cited by 46 · see citing works

Effects of external radiotherapy on uterine blood flow in patients with advanced cervical carcinoma assessed by Color Doppler ultrasonography

PIRHONEN, J. P., Grénman, S., Bredbacka, Å. B., Bahado-Singh, R. O., & Salmi, T. (1995) · Cancer · doi:10.1002/1097-0142(19950701)76:1 · Cited by 46 · see citing works

Soluble and cell-associated transferrin receptor in lung cancer

Dowlati, A., Loo, M., Bury, T., Fillet, G., & Beguin, Y. P. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.307 · Cited by 42 · see citing works

Roles of hormone replacement therapy and iron in proliferation of breast epithelial cells with different estrogen and progesterone receptor status

Dai, J., Jian, J., Bosland, M. C., Frenkel, K., Bernhardt, G., & Huang, X. (2007) · The Breast · doi:10.1016/j.breast.2007.08.009 · Cited by 42 · see citing works

Transferrin receptor (TrfR) expression in breast carcinoma and its possible relationship to prognosis

Wrba, F., Ritzinger, E., Reiner, A., & Holzner, J. H. (1986) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00710908 · Cited by 41 · see citing works

Phosphatidylinositol 3′-kinase, But Not p70 Ribosomal S6 Kinase, Is Involved in Membrane Protein Recycling: Wortmannin Inhibits Glucose Transport and Downregulates Cell-Surface Transferrin Receptor Numbers Independently of Any Effect on Fluid-phase Endocytosis in Fibroblasts

Jess, T. J., BELHAM, C. M., THOMSON, F. J., Scott, P., Plevin, R. J., & Gould, G. W. (1996) · Cellular Signalling · doi:10.1016/0898-6568(96)00054-x · Cited by 40 · see citing works

EGFR, c-erbB2 and p53 protein in the primary lesions and paired metastatic regional lymph nodes in breast cancer

Tsutsui, S., Ohno, S., Murakami, S., Kataoka, A., Kinoshita, J., & Hachitanda, Y. (2002) · European Journal of Surgical Oncology · doi:10.1053/ejso.2002.1259 · Cited by 40 · see citing works

Acquired resistance to oestrogen deprivation: role for growth factor signalling kinases/oestrogen receptor cross-talk revealed in new MCF-7X model

Staka, C. M., Nicholson, R. I., & Gee, J. M. W. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.01006 · Cited by 40 · see citing works

Transferrin receptor is inversely correlated with estrogen receptor in breast cancer

Tonik, S. E., Shindelman, J. E., & Sussman, H. H. (1986) · Breast Cancer Research and Treatment · doi:10.1007/bf01806791 · Cited by 36 · see citing works

Inhibition of growth of human breast carcinoma cells by an antisense oligonucleotide targeted to the transferrin receptor gene.

Yang, D. C., Jiang, X. P., Elliott, R. L., & Head, J. F. (2001) · PubMed · Cited by 34 · see citing works

Use of reverse transcription-polymerase chain reaction methodology to detect estrogen-regulated gene expression in small breast cancer specimens.

Knowlden, J. M., Gee, J. M. W., Bryant, S., McClelland, R. A., Manning, D. L., Mansel, R. E., Ellis, I. O., Blamey, R. W., Robertson, J. F. R., & Nicholson, R. I. (1997) · PubMed · Cited by 30 · see citing works

Transferrin receptor overexpression enhances transferrin responsiveness and the metastatic growth of a rat mammary adenocarcinoma cell line

Cavanaugh, P. G., Jia, L., Zou, Y., & Nicolson, G. L. (1999) · Breast Cancer Research and Treatment · doi:10.1023/a:1006209714287 · Cited by 29 · see citing works

Downregulation of transferrin receptor surface expression by intracellular antibody

Peng, J., Wu, S., Zhao, X., Wang, M., Li, W.-H., Shen, X., Liu, J., Lei, P., Zhu, H., & Shen, G. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.01.052 · Cited by 25 · see citing works

Iron and cancer: recent insights

Manz, D. H., Blanchette, N. L., Paul, B. T., Torti, F. M., & Torti, S. V. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13008 · Cited by 507 · see citing works

Iron and Cancer

Torti, S. V., Manz, D. H., Paul, B. T., Blanchette-Farra, N., & Torti, F. M. (2018) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-082117-051732 · Cited by 426 · see citing works

Transferrin receptor 1 in cancer: a new sight for cancer therapy.

Shen, Y., Li, X., Dong, D., Zhang, B., Xue, Y., & Shang, P. (2018) · Europe PMC (PubMed Central) · Cited by 357 · see citing works

Targeting iron metabolism in drug discovery and delivery

Crielaard, B. J., Lammers, T., & Rivella, S. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.248 · Cited by 352 · see citing works

Iron as a central player and promising target in cancer progression

Jung, M., Mertens, C., Tomat, E., & Brüne, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020273 · Cited by 268 · see citing works

Gallium and its competing roles with iron in biological systems.

Chitambar, C. (2016) · Biochimica et Biophysica Acta · doi:10.1016/j.bbamcr.2016.04.027 · Cited by 243 · see citing works

Antibodies Targeting the Transferrin Receptor 1 (TfR1) as Direct Anti-cancer Agents

Candelaria, P. V., Leoh, L. S., Penichet, M. L., & Daniels‐Wells, T. R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.607692 · Cited by 275 · see citing works

Doxorubicin-loaded human serum albumin nanoparticles surface-modified with TNF-related apoptosis-inducing ligand and transferrin for targeting multiple tumor types

Bae, S.-H., Ma, K., Kim, T. H., Lee, E. S., Oh, K. T., Park, E., Lee, K. C., & Youn, Y. S. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.10.050 · Cited by 236 · see citing works

Iron and Reactive Oxygen Species: Friends or Foes of Cancer Cells?

Bystrom, L. M., Guzman, M. L., & Rivella, S. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.5014 · Cited by 212 · see citing works

Role of ferritin alterations in human breast cancer cells

Shpyleva, S., Tryndyak, V., Kovalchuk, O., Starlard‐Davenport, A., Chekhun, V. F., Beland, F. A., & Pogribny, I. P. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0849-4 · Cited by 206 · see citing works

Gallium-Containing Anticancer Compounds

Chitambar, C. R. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.69 · Cited by 199 · see citing works

Ferroptosis in Cancer Treatment: Another Way to Rome

Wu, Y., Yu, C., Luo, M., Chen, C., Qiu, J., Zhang, S., & Hu, K. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.571127 · Cited by 176 · see citing works

Nanoparticle-based drug delivery systems targeting cancer cell surfaces

Hong, L., Li, W., Li, Y., & Yin, S. (2023) · RSC Advances · doi:10.1039/d3ra02969g · Cited by 183 · see citing works

Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer

Jou, Y.-J., Lin, C.-D., Lai, C., Chen, C.-H., Kao, J., Chen, S., Tsai, M.-H., Huang, S., & Lin, C.-W. (2010) · Analytica Chimica Acta · doi:10.1016/j.aca.2010.09.030 · Cited by 159 · see citing works

The crosstalk between autophagy and ferroptosis: what can we learn to target drug resistance in cancer?

Zhou, Y., Shen, Y., Chen, C., Sui, X., Yang, J., Wang, L., & Zhou, J. (2019) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2019.0158 · Cited by 154 · see citing works

Strategies for Targeting Gene Therapy in Cancer Cells With Tumor-Specific Promoters

Montaño-Samaniego, M., Bravo‐Estupiñan, D. M., Méndez-Guerrero, O., Alarcón-Hernández, E., & Ibáñez-Hernández, M. Á. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.605380 · Cited by 152 · see citing works

Erastin, a ferroptosis-inducing agent, sensitized cancer cells to X-ray irradiation via glutathione starvation in vitro and in vivo

Shibata, Y., Yasui, H., Higashikawa, K., Miyamoto, N., & Kuge, Y. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225931 · Cited by 145 · see citing works

Laser-based 3D bioprinting for spatial and size control of tumor spheroids and embryoid bodies

Kingsley, D. M., Roberge, C. L., Rudkouskaya, A., Faulkner, D. E., Barroso, M., Intes, X., & Corr, D. T. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.02.014 · Cited by 132 · see citing works

A concise review on cancer treatment methods and delivery systems

Bidram, E., Esmaeili, Y., Ranji‐Burachaloo, H., Al-Zaubai, N., Zarrabi, A., Stewart, A. G., & Dunstan, D. E. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.101350 · Cited by 120 · see citing works

Coexpression of CD71 and CD117 Identifies an Early Unipotent Neutrophil Progenitor Population in Human Bone Marrow

Dinh, H. Q., Eggert, T., Meyer, M. A., Zhu, Y. P., Olingy, C. E., Llewellyn, R. A., Wu, R., & Hedrick, C. C. (2020) · Immunity · doi:10.1016/j.immuni.2020.07.017 · Cited by 120 · see citing works

Transferrin-binding peptide functionalized polymersomes mediate targeted doxorubicin delivery to colorectal cancer in vivo

Wei, Y., Gu, X., Sun, Y., Meng, F., Storm, G., & Zhong, Z. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.012 · Cited by 117 · see citing works

Iron homeostasis in breast cancer

Marques, O., da Silva, B. M., Porto, G., & Lopes, C. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.01.029 · Cited by 115 · see citing works

Suicide Gene Therapy for Cancer; Old Dog New Tricks

Zarogoulidis, P. (2013) · Journal of Genetic Syndromes & Gene Therapy · doi:10.4172/2157-7412.1000139 · Cited by 110 · see citing works

Macrophage iron homeostasis and polarization in the context of cancer

Jung, M., Mertens, C., & Brüne, B. (2014) · Immunobiology · doi:10.1016/j.imbio.2014.09.011 · Cited by 103 · see citing works

Tumor-initiating cells of breast and prostate origin show alterations in the expression of genes related to iron metabolism

Rychtarcikova, Z., Lettlova, S., Tomkova, V., Korenkova, V., Langerova, L., Simonova, E., Zjablovskaja, P., Alberich-Jorda, M., Neuzil, J., & Truksa, J. (2017) · Oncotarget · doi:10.18632/oncotarget.14093 · Cited by 100 · see citing works

Clinical and biological significance of glucocorticoid receptor (GR) expression in breast cancer

Abduljabbar, R. F., Negm, O. H., Lai, C., Jerjees, D. A., Al-kaabi, M. M., Hamed, M. R., Tighe, P. J., Buluwela, L., Mukherjee, A., Green, A. R., et al. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3335-1 · Cited by 98 · see citing works

Receptor-based Targeting of Therapeutics

Mehra, N. K., Mishra, V. K., & Jain, N. K. (2013) · Therapeutic Delivery · doi:10.4155/tde.13.6 · Cited by 97 · see citing works

Iron metabolism and drug resistance in cancer

Kazan, H. H., Urfali‐Mamatoglu, C., & Gündüz, U. (2017) · BioMetals · doi:10.1007/s10534-017-0037-7 · Cited by 95 · see citing works

Receptor-Targeted Nanomedicine for Cancer Therapy

Prajapati, A., Rangra, S., Patil, R., Desai, N., Jyothi, V. G. S. S., Salave, S., Amate, P., Benival, D. M., & Kommineni, N. (2024) · Receptors · doi:10.3390/receptors3030016 · Cited by 98 · see citing works

Cellular Iron Metabolism in Prognosis and Therapy of Breast Cancer

Torti, S. V., & Torti, F. M. (2013) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2013007784 · Cited by 93 · see citing works

The prognostic significance of PELP1 expression in invasive breast cancer with emphasis on the ER-positive luminal-like subtype

Habashy, H. O., Powe, D. G., Rakha, E. A., Ball, G., Macmillan, R. D., Green, A. R., & Ellis, I. O. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0419-9 · Cited by 91 · see citing works

High-Dose Deferoxamine Treatment Disrupts Intracellular Iron Homeostasis, Reduces Growth, and Induces Apoptosis in Metastatic and Nonmetastatic Breast Cancer Cell Lines

Bajbouj, K., Shafarin, J., & Hamad, M. A. (2018) · Technology in Cancer Research & Treatment · doi:10.1177/1533033818764470 · Cited by 89 · see citing works

Cancer cells with irons in the fire

Bystrom, L. M., & Rivella, S. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.04.035 · Cited by 89 · see citing works

Transferrin receptor 1 upregulation in primary tumor and downregulation in benign kidney is associated with progression and mortality in renal cell carcinoma patients

Greene, C. J., Attwood, K., Sharma, N. J., Gross, K. W., Smith, G. J., Xu, B., & Kauffman, E. C. (2017) · Oncotarget · doi:10.18632/oncotarget.22323 · Cited by 87 · see citing works

Overexpression of transferrin receptor CD71 and its tumorigenic properties in esophageal squamous cell carcinoma

CHAN, K. T., Choi, M. Y., Lai, K., Tan, W., Tung, L. N., Lam, H. Y., Tong, D. K. H., Lee, N. P. Y., & Law, S. Y.-K. (2014) · Oncology Reports · doi:10.3892/or.2014.2981 · Cited by 86 · see citing works

Macrophage-derived lipocalin-2 transports iron in the tumor microenvironment

Mertens, C., Mora, J., Ören, B., Grein, S., Winslow, S., Scholich, K., Weigert, A., Malmström, P., Forsare, C., Fernö, M., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2017.1408751 · Cited by 85 · see citing works

Intracellular Iron Chelation Modulates the Macrophage Iron Phenotype with Consequences on Tumor Progression

Mertens, C., Akam, E. A., Rehwald, C., Brüne, B., Tomat, E., & Jung, M. (2016) · PLOS ONE · doi:10.1371/journal.pone.0166164 · Cited by 83 · see citing works

Src Regulates Tyr20 Phosphorylation of Transferrin Receptor-1 and Potentiates Breast Cancer Cell Survival

Jian, J., Yang, Q., & Huang, X. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.271585 · Cited by 77 · see citing works

Emerging Mechanisms and Disease Implications of Ferroptosis: Potential Applications of Natural Products

Ge, C., Zhang, S., Mu, H., Shaojun, Z., Tan, Z., Huang, X., Chen, X., Zou, J., Zhu, Y., Dong, F., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.774957 · Cited by 77 · see citing works

TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer

Cheng, X., Fan, K., Wang, L., Ying, X., Sanders, A. J., Guo, T., Xing, X., Zhou, M., Du, H., Hu, Y., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2272-z · Cited by 75 · see citing works

ELF5 Drives Lung Metastasis in Luminal Breast Cancer through Recruitment of Gr1+ CD11b+ Myeloid-Derived Suppressor Cells

Gallego‐Ortega, D., Ledger, A., Roden, D. L., Law, A. M. K., Magenau, A., Kikhtyak, Z., Cho, C., Allerdice, S. L., Lee, H. J., Valdés‐Mora, F., et al. (2015) · PLoS Biology · doi:10.1371/journal.pbio.1002330 · Cited by 72 · see citing works

The iron chelator deferasirox synergises with chemotherapy to treat triple‐negative breast cancers

Tury, S., Assayag, F., Bonin, F., Château‐Joubert, S., Servely, J., Vacher, S., Becette, V., Caly, M., Rapinat, A., Gentien, D., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5104 · Cited by 71 · see citing works

Phase I, First-in-Human Study of the Probody Therapeutic CX-2029 in Adults with Advanced Solid Tumor Malignancies

Johnson, M., El-Khoueiry, A., Hafez, N., Lakhani, N., Mamdani, H., Rodon, J., Sanborn, R. E., Garcia-Corbacho, J., Boni, V., Stroh, M., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-0194 · Cited by 72 · see citing works

Perturbation of Iron Metabolism by Cisplatin through Inhibition of Iron Regulatory Protein 2

Miyazawa, M., Bogdan, A. R., & Tsuji, Y. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2018.10.009 · Cited by 70 · see citing works

Deferoxamine Promotes MDA-MB-231 Cell Migration and Invasion through Increased ROS-Dependent HIF-1a Accumulation

Liu, Y., Cui, Y., Shi, M., Zhang, Q., Wang, Q., & Chen, X. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358674 · Cited by 69 · see citing works

Iron Dysregulation in Human Cancer: Altered Metabolism, Biomarkers for Diagnosis, Prognosis, Monitoring and Rationale for Therapy

Lelièvre, P., Sancey, L., Coll, J., Deniaud, A., & Busser, B. (2020) · Cancers · doi:10.3390/cancers12123524 · Cited by 66 · see citing works

Iron-Targeting Antitumor Activity of Gallium Compounds and Novel Insights Into Triapine ® -Metal Complexes

Chitambar, C. R., & Antholine, W. E. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4880 · Cited by 65 · see citing works

Targeted Co-delivery of the Iron Chelator Deferoxamine and a HIF1α Inhibitor Impairs Pancreatic Tumor Growth

Lang, J., Zhao, X., Wang, X., Zhao, Y., Li, Y., Zhao, R., Cheng, K., Li, Y., Han, X., Zheng, X., et al. (2019) · ACS Nano · doi:10.1021/acsnano.8b08823 · Cited by 61 · see citing works

Lipocalin-2 and iron trafficking in the tumor microenvironment

Jung, M., Mertens, C., Bauer, R., Rehwald, C., & Brüne, B. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.03.018 · Cited by 60 · see citing works

miR-148a regulates expression of the transferrin receptor 1 in hepatocellular carcinoma

Babu, K. R., & Muckenthaler, M. U. (2019) · Scientific Reports · doi:10.1038/s41598-018-35947-7 · Cited by 60 · see citing works

Transferrin receptor 1 targeted nanomedicine for brain tumor therapy

Li, J., Zhang, Z., Zhang, B., Yan, X., & Fan, K. (2023) · Biomaterials Science · doi:10.1039/d2bm02152h · Cited by 58 · see citing works

Quantitative Analysis of Transferrin Receptor 1 (TfR1) in Individual Breast Cancer Cells by Means of Labeled Antibodies and Elemental (ICP-MS) Detection

Corte‐Rodríguez, M., Blanco‐González, E., Bettmer, J., & Montes‐Bayón, M. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b03438 · Cited by 58 · see citing works

Genome Wide Expression Profiling of Cancer Cell Lines Cultured in Microgravity Reveals Significant Dysregulation of Cell Cycle and MicroRNA Gene Networks

Vidyasekar, P., Shyamsunder, P., Arun, R. P., Santhakumar, R., Kapadia, N. K., Kumar, R., & Verma, R. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135958 · Cited by 57 · see citing works

Regulation of transferrin receptor-1 mRNA by the interplay between IRE-binding proteins and miR-7/miR-141 in the 3′-IRE stem–loops

Miyazawa, M., Bogdan, A. R., Hashimoto, K., & Tsuji, Y. (2018) · RNA · doi:10.1261/rna.063941.117 · Cited by 53 · see citing works

Toxicity Tolerance in the Carcinogenesis of Environmental Cadmium

Ćirović, A., & Satarug, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031851 · Cited by 54 · see citing works

Cytotoxic Activities of Silver Nanoparticles and Silver Ions in Parent and Tamoxifen-Resistant T47D Human Breast Cancer Cells and Their Combination Effects with Tamoxifen against Resistant Cells.

Ostad, S. N., Dehnad, S., Nazari, Z. E., Tavajohi, S., Mokhtari, N., Shakibaie, M., & Shahverdi, A. R. (2010) · Europe PMC (PubMed Central) · Cited by 52 · see citing works

Silencing the Peroxiredoxin III gene inhibits cell proliferation in breast cancer

Bay (2009) · International Journal of Oncology · doi:10.3892/ijo_00000507 · Cited by 52 · see citing works

Iron, Oxidative Damage and Ferroptosis in Rhabdomyosarcoma

Fanzani, A., & Poli, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081718 · Cited by 50 · see citing works

RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: a marker of ER-positive luminal-like subtype

Habashy, H. O., Powe, D. G., Glaab, E., Ball, G., Spiteri, I., Krasnogor, N., Garibaldi, J. M., Rakha, E. A., Green, A. R., Caldas, C., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1073-y · Cited by 50 · see citing works

Deferoxamine Enhanced Mitochondrial Iron Accumulation and Promoted Cell Migration in Triple-Negative MDA-MB-231 Breast Cancer Cells Via a ROS-Dependent Mechanism

Chen, C., Wang, S., & Liu, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194952 · Cited by 49 · see citing works

DeePaN: deep patient graph convolutional network integrating clinico-genomic evidence to stratify lung cancers for immunotherapy

Fang, C., Xu, D. H., Su, J., Dry, J. R., & Linghu, B. (2021) · npj Digital Medicine · doi:10.1038/s41746-021-00381-z · Cited by 50 · see citing works

Selection of superior targeting ligands using PEGylated PLGA nanoparticles for delivery of curcumin in the treatment of triple-negative breast cancer cells

Prabhuraj, R. S., Bomb, K., Srivastava, R., & Bandyopadhyaya, R. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101722 · Cited by 48 · see citing works

Isolation, Characterization and Bioactivities of an Extracellular Polysaccharide Produced from Streptomyces sp. MOE6

Elnahas, M. O., Amin, M. A., Hussein, M., Shanbhag, V., Ali, A. E., & Wall, J. D. (2017) · Molecules · doi:10.3390/molecules22091396 · Cited by 47 · see citing works

Iron metabolism and the tumor microenvironment: A new perspective on cancer intervention and therapy (Review)

bu, X., & Wang, L. (2024) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2024.5480 · Cited by 49 · see citing works

The iron load of lipocalin-2 (LCN-2) defines its pro-tumour function in clear-cell renal cell carcinoma

Rehwald, C., Schnetz, M., Urbschat, A., Mertens, C., Meier, J. K., Bauer, R., Baer, P. C., Winslow, S., Roos, F. C., Zwicker, K., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0655-7 · Cited by 44 · see citing works

Nrf2 Is a Potential Modulator for Orchestrating Iron Homeostasis and Redox Balance in Cancer Cells

Zhang, L., Zhang, J., Jin, Y., Yao, G., Zhao, H., Qiao, P., & Wu, S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.728172 · Cited by 42 · see citing works

Nonclinical Efficacy and Safety of CX-2029, an Anti-CD71 Probody–Drug Conjugate

Singh, S., Serwer, L., DuPage, A., Elkins, K., Chauhan, N., Ravn, M., Buchanan, F., Wang, L., Krimm, M., Wong, K., et al. (2022) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-21-0193 · Cited by 41 · see citing works

Deferoxamine-induced high expression of TfR1 and DMT1 enhanced iron uptake in triple-negative breast cancer cells by activating IL-6/PI3K/AKT pathway

Chen, C., Liu, P., Duan, X., Cheng, M. S., & Xu, L. X. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s193507 · Cited by 41 · see citing works

Therapeutic applications of CRISPR/Cas9 in breast cancer and delivery potential of gold nanomaterials

Padayachee, J., & Singh, M. (2020) · Nanobiomedicine · doi:10.1177/1849543520983196 · Cited by 39 · see citing works

Andrographolide regulates epidermal growth factor receptor and transferrin receptor trafficking in epidermoid carcinoma (A‐431) cells

Tan, Y. R., Chiow, K. H., Huang, D., & Wong, S. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00627.x · Cited by 39 · see citing works

Harnessing molecular recognition for localized drug delivery

Liu, R., Zuo, R., & Hudalla, G. A. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.008 · Cited by 38 · see citing works

An affordable label-free ultrasensitive immunosensor based on gold nanoparticles deposited on glassy carbon electrode for the transferrin receptor detection

Ahmad, A., Rabbani, G., Zamzami, M. A., Hosawi, S. B. I., Baothman, O. A. S., Altayeb, H. N., Akhtar, M. S. N., Ahmad, V., Khan, M. V., Khan, M. E., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.133083 · Cited by 37 · see citing works

Inactivation of MYO5B Promotes Invasion and Motility in Gastric Cancer Cells

Dong, W., Chen, X., Chen, P., Yue, D., Zhu, L., & Fan, Q. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1989-z · Cited by 37 · see citing works

DCYTB is a predictor of outcome in breast cancer that functions via iron-independent mechanisms

Lemler, D. J., Lynch, M. L., Tesfay, L., Deng, Z., Paul, B. T., Wang, X., Hegde, P., Manz, D. H., Torti, S. V., & Torti, F. M. (2017) · Breast Cancer Research · doi:10.1186/s13058-017-0814-9 · Cited by 37 · see citing works

Noninvasive 89 Zr-Transferrin PET Shows Improved Tumor Targeting Compared with 18 F-FDG PET in MYC-Overexpressing Human Triple-Negative Breast Cancer

Henry, K. E., Dilling, T. R., Abdel-Atti, D., Edwards, K. J., Evans, M. J., & Lewis, J. S. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.192286 · Cited by 37 · see citing works

Identification of Iron Metabolism-Related Genes as Prognostic Indicators for Lower-Grade Glioma

Xu, S., Wang, Z., Ye, J., Mei, S., & Zhang, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.729103 · Cited by 36 · see citing works

Development of a complete human IgG monoclonal antibody to transferrin receptor 1 targeted for adult T-cell leukemia/lymphoma

Shimosaki, S., Nakahata, S., Ichikawa, T., Kitanaka, A., Kameda, T., Hidaka, T., Kubuki, Y., Kurosawa, G., Zhang, L., Sudo, Y., et al. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.02.039 · Cited by 36 · see citing works

Doxorubicin–transferrin conjugate alters mitochondrial homeostasis and energy metabolism in human breast cancer cells

Wigner, P., Zieliński, K. W., Łabieniec-Watała, M., Marczak, A., & Szwed, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-84146-4 · Cited by 36 · see citing works

Smap1 deficiency perturbs receptor trafficking and predisposes mice to myelodysplasia

Kon, S., Minegishi, N., Tanabe, K., Watanabe, T., Funaki, T., Wong, W. F., Sakamoto, D., Higuchi, Y., Kiyonari, H., Asano, K., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci63711 · Cited by 35 · see citing works

Proteomic-Based Biosignatures in Breast Cancer Classification and Prediction of Therapeutic Response

He, J., Whelan, S. A., Lu, M., Shen, D., Chung, D. U., Saxton, R. E., Faull, K. F., Whitelegge, J. P., & Chang, H. R. (2011) · International Journal of Proteomics · doi:10.1155/2011/896476 · Cited by 34 · see citing works

Engineered ferritin for lanthanide binding

Calisti, L., Trabuco, M. C., Boffi, A., Testi, C., Montemiglio, L. C., Georges, A. D., Benni, I., Ilari, A., Taciak, B., Białasek, M., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201859 · Cited by 34 · see citing works

Carcinogenesis as Side Effects of Iron and Oxygen Utilization: From the Unveiled Truth toward Ultimate Bioengineering

Toyokuni, S., Kong, Y., Cheng, Z., Sato, K., Hayashi, S., Ito, F., Jiang, L., Yanatori, I., Okazaki, Y., & Akatsuka, S. (2020) · Cancers · doi:10.3390/cancers12113320 · Cited by 33 · see citing works

Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer

Chen, F., Fan, Y., Hou, J., Liu, B., Zhang, B., Shang, Y., Chang, Y.-Z., Cao, P., & Tan, K. (2021) · Aging · doi:10.18632/aging.203512 · Cited by 33 · see citing works

L-ferritin: A theranostic agent of natural origin for MRI visualization and treatment of breast cancer

Bitonto, V., Alberti, D., Ruiu, R., Aime, S., Crich, S. G., & Cutrìn, J. C. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.12.051 · Cited by 32 · see citing works

Iron chelation: an adjuvant therapy to target metabolism, growth and survival of murine PTEN-deficient T lymphoma and human T lymphoblastic leukemia/lymphoma

Benadiba, J., Rosilio, C., Nebout, M., Heimeroth, V., Neffati, Z., Popa, A., Mary, D. A. S. G., Griessinger, E., Imbert, V., Sirvent, N., et al. (2016) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2016.1239257 · Cited by 32 · see citing works

Expression of Iron-Related Proteins Differentiate Non-Cancerous and Cancerous Breast Tumors

Pizzamiglio, S., Bortoli, M. D., Taverna, E., Signore, M., Veneroni, S., Cho, W., Orlandi, R., Verderio, P., & Bongarzone, I. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020410 · Cited by 32 · see citing works

Enhanced expression of transferrin receptor 1 contributes to oncogenic signalling by sphingosine kinase 1

Pham, D., Powell, J. A., Gliddon, B. L., Moretti, P. A. B., Tsykin, A., der Hoek, M. B. V., Kenyon, R. R., Goodall, G. J., & Pitson, S. M. (2013) · Oncogene · doi:10.1038/onc.2013.502 · Cited by 31 · see citing works

Sinomenine hydrochloride enhancement of the inhibitory effects of anti-transferrin receptor antibody-dependent on the COX-2 pathway in human hepatoma cells

Hong, Y., Yang, J., Shen, X., Zhu, H., Sun, X., Wen, X., Bian, J., Hu, H., Yuan, L., Tao, J., et al. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1337-y · Cited by 30 · see citing works

Cancer: Tumor Iron Metabolism, Mitochondrial Dysfunction and Tumor Immunosuppression; “A Tight Partnership—Was Warburg Correct?”

Elliott, R. L., & Head, J. F. (2012) · Journal of Cancer Therapy · doi:10.4236/jct.2012.34039 · Cited by 30 · see citing works

CD71 in Gestational Pathology

Luchini, C., Parcesepe, P., Nottegar, A., Parolini, C., Mafficini, A., Remo, A., Chilosi, M., & Manfrin, E. (2015) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000175 · Cited by 30 · see citing works

Blocking transferrin receptor inhibits the growth of lung adenocarcinoma cells in vitro

Wu, Y., Xu, J., Chen, J., Zou, M., Rusidanmu, A., & Yang, R. (2017) · Thoracic Cancer · doi:10.1111/1759-7714.12572 · Cited by 30 · see citing works

Bionano Interactions of MCF-7 Breast Tumor Cells with a Transferrin Receptor Targeted Nanoparticle

Du, W., Fan, Y., He, B., Zheng, N., Yuan, L., Dai, W., Zhang, H., Wang, X., Wang, J., Zhang, X., et al. (2015) · Molecular Pharmaceutics · doi:10.1021/mp500796d · Cited by 29 · see citing works

Generating Giant Membrane Vesicles from Live Cells with Preserved Cellular Properties

Liu, Q., Bi, C., Li, J., Liu, X., Peng, R., Jin, C. Y., Sun, Y., Lyu, Y., Liu, H., Wang, H., et al. (2019) · Research · doi:10.34133/2019/6523970 · Cited by 29 · see citing works

Activated zinc transporter ZIP7 as an indicator of anti-hormone resistance in breast cancer

Ziliotto, S., Gee, J. M. W., Ellis, I. O., Green, A. R., Finlay, P., Gobbato, A., & Taylor, K. M. (2019) · Metallomics · doi:10.1039/c9mt00136k · Cited by 29 · see citing works

The ITIM-Containing Receptor: Leukocyte-Associated Immunoglobulin-Like Receptor-1 (LAIR-1) Modulates Immune Response and Confers Poor Prognosis in Invasive Breast Carcinoma

Joseph, C., Alsaleem, M. A., Toss, M. S., Kariri, Y. A., Althobiti, M. M., Alsaeed, S. A., Aljohani, A., Narasimha, P. L., Mongan, N. P., Green, A. R., et al. (2020) · Cancers · doi:10.3390/cancers13010080 · Cited by 29 · see citing works

Candidate early detection protein biomarkers for ER+/PR+ invasive ductal breast carcinoma identified using pre-clinical plasma from the WHI observational study

Buas, M. F., Rho, J.-H., Chai, X., Zhang, Y., Lampe, P. D., & Li, C. I. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3554-5 · Cited by 29 · see citing works

Transferrin receptor in primary and metastatic breast cancer: Evaluation of expression and experimental modulation to improve molecular targeting

Fontana, F., Esser, A. K., Egbulefu, C., Karmakar, P. S., Su, X., Allen, J. S., Xu, Y., Davis, J. L., Gabay, A. J., Xiang, J., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0293700 · Cited by 30 · see citing works

Optimized Doxorubicin Chemotherapy for Diffuse Large B-cell Lymphoma Exploits Nanocarrier Delivery to Transferrin Receptors

Arumov, A., Liyanage, P. Y., Trabolsi, A., Roberts, E. R., Li, L., Ferreira, B. C. L. B., Gao, Z., Ban, Y. J., Newsam, A. D., Taggart, M. W., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2674 · Cited by 28 · see citing works

Estrogen-induced disruption of intracellular iron metabolism leads to oxidative stress, membrane damage, and cell cycle arrest in MCF-7 cells

Bajbouj, K., Shafarin, J., Abdalla, M. Y., Ahmad, I. M., & Hamad, M. A. (2017) · Tumor Biology · doi:10.1177/1010428317726184 · Cited by 28 · see citing works

Myeloid deletion of phosphoinositide-dependent kinase-1 enhances NK cell-mediated antitumor immunity by mediating macrophage polarization

He, Y., Du, J., & Dong, Z. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1774281 · Cited by 28 · see citing works

Abstract P2-06-19: Transferrin Receptor (CD71) Identifies Poor Response to Tamoxifen in Oestrogen Receptor Positive Breast Cancer Patients

Nicholson, R., Habashy, H., Gee, J. M. W., Finlay, P., Farrow, L., Jasani, B., Barrett-Lee, P. J., Robertson, J. F. R., & Ellis, I. O. (2010) · Cancer Research · doi:10.1158/0008-5472.sabcs10-p2-06-19

Экспрессия рецептора трансферрина (СD71) клетками рака молочной железы

Артамонова, Е. В., Григорьевна, К. З., Летягин, В. П., Ermilova, V. D., Ognerubov, N. A., & Tupitsyn, N. N. (2003) · Medical Immunology (Russia)

Expression of transferrin receptor 1 and β1-integrins correlates with estrogen receptor status and immune infiltration in breast cancer

Чулкова, С. В., Шолохова, Е. Н., Poddubnaya, I. V., Гладилина, И. А., Владимировна, Е. А., & Stilidi, I. S. (2024) · Russian Journal of Archive of Pathology · doi:10.17116/patol20248604123

PP-1-11 Transferrin receptor (cd71) expression by human breast cancer cells

Артамонова, Е. В., Vasiliev, M. V., Tupitsyn, N. M., Ognerobov, N. A., & Григорьевна, К. З. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)84051-2

Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan

Hiscox, S., Baruah, B. P., Smith, C. R., Bellerby, R., Goddard, L., Jordan, N., Poghosyan, Z. P., Nicholson, R. I., Barrett-Lee, P. J., & Gee, J. M. W. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-458 · Cited by 70 · see citing works